Cargando…

Long-term effects of the SLC2A9 G844A and SLC22A12 C246T variants on serum uric acid concentrations in children

BACKGROUND: We evaluated the effects of two single-nucleotide polymorphisms on UA concentrations in the first decade of life using repeated-measures data. METHODS: We included all subjects who were followed-up at least once and for whom we had both UA and genotypic data (i.e., 375, 204, 307, and 363...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye Ah, Park, Bo Hyun, Park, Eun Ae, Cho, Su Jin, Kim, Hae Soon, Park, Hyesook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127956/ https://www.ncbi.nlm.nih.gov/pubmed/30189835 http://dx.doi.org/10.1186/s12887-018-1272-y

Ejemplares similares

SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration
por: Ware, Erin B., et al.
Publicado: (2015)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

Copy number polymorphisms near SLC2A9 are associated with serum uric acid concentrations
por: Scharpf, Robert B, et al.
Publicado: (2014)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

A population-specific low-frequency variant of SLC22A12 (p.W258*) explains nearby genome-wide association signals for serum uric acid concentrations among Koreans
por: Im, Sun-Wha, et al.
Publicado: (2020)

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M)
por: Perdomo-Ramirez, Ana, et al.
Publicado: (2023)

Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes
por: Cha, Do Hyeon, et al.
Publicado: (2019)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

Gene Dose-Dependent and Additive Effects of ABCG2 rs2231142 and SLC2A9 rs3733591 Genetic Polymorphisms on Serum Uric Acid Levels
por: Park, Jin-Woo, et al.
Publicado: (2022)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Overexpression of Uric Acid Transporter SLC2A9 Inhibits Proliferation of Hepatocellular Carcinoma Cells
por: Han, Xiaoying, et al.
Publicado: (2019)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population
por: Liu, Jia, et al.
Publicado: (2020)

Complex Analysis of Urate Transporters SLC2A9, SLC22A12 and Functional Characterization of Non-Synonymous Allelic Variants of GLUT9 in the Czech Population: No Evidence of Effect on Hyperuricemia and Gout
por: Hurba, Olha, et al.
Publicado: (2014)

Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability
por: Lee, Beomki, et al.
Publicado: (2023)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

Serum uric acid distribution according to SLC22A12 W258X genotype in a cross-sectional study of a general Japanese population
por: Hamajima, Nobuyuki, et al.
Publicado: (2011)

Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels
por: Higashino, Toshihide, et al.
Publicado: (2020)

SLC-2000: a luminosity upgrade for the SLC
por: Breidenbach, M, et al.
Publicado: (1996)

Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study
por: Zhou, Zhao-Wei, et al.
Publicado: (2015)

NO ASSOCIATION BETWEEN MTHFR C677T AND SERUM URIC ACID LEVELS AMONG JAPANESE WITH ABCG2 126QQ AND SLC22A12 258WW
por: HINOHARA, YUKAKO, et al.
Publicado: (2013)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

SLC2A12 of SLC2 Gene Family in Bird Provides Functional Compensation for the Loss of SLC2A4 Gene in Other Vertebrates
por: Xiong, Ying, et al.
Publicado: (2020)

Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy
por: Damanskienė, Eligija, et al.
Publicado: (2022)

Erratum to: Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study
por: Zhou, Zhao-Wei, et al.
Publicado: (2015)

Associations of Serum Uric Acid and SLC2A9 Variant with Depressive and Anxiety Disorders: A Population-Based Study
por: Lyngdoh, Tanica, et al.
Publicado: (2013)

The effects of URAT1/SLC22A12 nonfunctional variants,R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression
por: Sakiyama, Masayuki, et al.
Publicado: (2016)

Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice
por: Alshahrani, Saeed, et al.
Publicado: (2015)

The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans
por: Nies, Anne T., et al.
Publicado: (2020)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI
por: Brandstätter, Anita, et al.
Publicado: (2008)

The Single Nucleotide Polymorphism rs1014290 of the SLC2A9 Gene Is Associated with Uric Acid Metabolism in Parkinson's Disease
por: Miao, Jiangfang, et al.
Publicado: (2017)

Exonic deletion of SLC9A9 in autism with epilepsy
por: Cardon, Meeta, et al.
Publicado: (2016)

The Genetic Variability of Members of the SLC38 Family of Amino Acid Transporters (SLC38A3, SLC38A7 and SLC38A9) Affects Susceptibility to Type 2 Diabetes and Vascular Complications
por: Crocco, Paolina, et al.
Publicado: (2022)

Polymorphisms of ABCG2 and SLC22A12 Genes Associated with Gout Risk in Vietnamese Population
por: Thuy Duong, Nguyen, et al.
Publicado: (2019)

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels
por: Misawa, Kazuharu, et al.
Publicado: (2020)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hmpmgjvjprraea4oeh4lkgs6sr